Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study.
Leuk Lymphoma
; 64(2): 468-472, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36593729
Full text:
1
Database:
MEDLINE
Main subject:
Neoplasms, Plasma Cell
/
Multiple Myeloma
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Leuk Lymphoma
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2023
Type:
Article
Affiliation country:
Sweden